Potassium Chloride Tablet, Extended Release
Product Images NDC 68382-861

Each extended-release tablet provides 750mg potassium chloride USP (equivalent to 10 mEq of potassium). The package insert for extended-release complete prescribing information should be consulted for usual dosage. The tablets should be stored at 20° to 25°C (68° to 77°F) and dispensed in a high, light-resistant USP defined container. The drug should be kept out of the reach of children. The USP assay preparation is pending. It is manufactured by Cadila Healthcare Ltd. in Matoda, Ahmedabad, India, and distributed in 100-tablet bottles by 2ydus Pharmaceuticals USA Inc. in Pennington, NJ 08534.*

Potassium Chloride Extended-release Tablets, USP are prescription drugs that come in a bottle containing 100 tablets. Each tablet provides 1500mg of potassium chloride USP, which is equivalent to 20 mEq of potassium. These tablets are designed for extended-release and should be stored in a tightly closed, light-resistant container at room temperature. The usual dosage of the tablets should be determined according to the prescribing information provided in the package insert. The manufacture of these tablets is by Cadila Healthcare Ltd in India, and they are distributed by Zydus Pharmaceuticals USA Inc. in Pennington, NJ. The USP assay preparation is pending. Keep this and all drugs out of reach of children.*